0
Skip to content

California District Court Partially Dismisses Class-Action Lawsuit Against CRAs

court scale with bookThe California doctor who brought the action against TransUnion, Equifax and Experian was granted leave to amend within 30 days, with the court ultimately dismissing the class’s antitrust and Cartwright Act claims.

01/16/2025 2:05 P.M.

3 minute read

The class-action lawsuit a California physician filed against TransUnion, Equifax and Experian back in September 2023 has been partially dismissed, according to a new order (PDF) from the U.S. District Court for the Eastern District of California released early this year.

Background

In September 2023, the plaintiff Dr. Derrick Adams, brought the class-action lawsuit against the three major credit reporting agencies (CRAs) for allegedly conspiring to remove unpaid medical bills under $500 from consumers’ credit reports—causing increased costs for medical providers and reduced access to care for patients.

The lawsuit from Adams, owner of Twelve Bridges Dermatology in Lincoln, California, alleged on behalf of similarly situated providers that the CRAs’ actions are in violation of the Sherman Antitrust Act and California’s Cartwright Act, ACA International previously reported.

“While the [d]efendants celebrated their joint action as benefitting patients, the agreement represents a categorical violation of the Sherman Act and the Cartwright Act, and its imposition not only illegally restrains trade, but will also diminish access to medical care by driving providers out of certain markets,” Adams’ complaint (PDF) states.

The lawsuit argued the CRAs’ “conspiracy to devalue their credit reports, by agreeing not to report unpaid medical bills under $500, targets medical providers and has inevitably harmed them. Medical providers now have a more costly path to collect payment on unpaid medical bills, if they can feasibly collect at all. Defendants’ conduct also places individual medical providers, such as Dr. Adams, at a severe financial disadvantage compared to larger and more expensive medical practices, such as hospitals.”

Adams and the class in the lawsuit sought damages in an amount to be proven at trial.

Decision and Partial Dismissal

Analyzing the defendants’ motion under Rule 12(b)(1), the court concluded that the plaintiffs have met their burden of showing predictable third-party reactions signifying Article III standing based on personal pocketbook injury and declined to dismiss the lawsuit based on of lack of standing.

Conversely, the court found that the plaintiffs failed to show antitrust standing as their injuries were too “remote, too speculative, and [did] not occur in the relevant market,” and that the pleadings indicate “that there are more direct victims of [the d]efendants’ allegedly anticompetitive behavior.”

Ultimately, the court granted the plaintiffs leave to amend the lawsuit within 30 days. It also declined to exercise supplemental jurisdiction over state law claims after dismissing all federal claims and dismissing the plaintiffs’ Cartwright Act claim without prejudice. This is subject to an amended complaint stating a valid federal claim.

Read the order here (PDF).

Remember, subscribe to ACA Daily and Member Alerts under your My ACA profile when logged in to acainternational.org.

If you have executive leadership updates or other member news to share with ACA, contact our communications department at comm@acainternational.org. View our publications page for more information and our news submission guidelines here.

One moment please...

Share Profile

This site utilizes cookies as included in our Privacy Policy and User Agreement.